The Delaware hearings are viewed as the greatest near-term chance that the class actions against ranitidine manufacturers will be revived, and whether GSK may consider additional settlements.

It is also facing a class action suit alleging economic injury ... business - although it says it is not a party to any of the Zantac claims. Meanwhile, Sanofi, Pfizer and Boehringer Ingelheim ...

Rosenberg dismissed every Zantac lawsuit filed in the multidistrict litigation class in December 2022, said Miller & Zois Attorneys at Law. That still left cases in state courts. The Financial ...

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

(RTTNews) - GSK plc (GSK, GSK.L) announced that it has reached agreements with 10 plaintiff firms representing approximately 93% (around 80,000) of the Zantac (ranitidine) product liability cases ...

GSK said total sales fell by two per cent in the third quarter Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and ...

(WJET/WFXP) — UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed that the now ...

The Zantac dispute stems from 2019 ... legal claims relating to alleged privacy breaches in the Netherlands. The class action claims are currently subject to an appeal. TikTok, owned by Beijing ...

The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...

On Tuesday, U.S. District Judge Brian Cogan in New York dismissed key consumer claims in the multidistrict litigation against ...